Little House Capital LLC Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Little House Capital LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 33.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,595 shares of the healthcare conglomerate’s stock after buying an additional 2,888 shares during the quarter. UnitedHealth Group comprises 1.9% of Little House Capital LLC’s holdings, making the stock its 16th largest position. Little House Capital LLC’s holdings in UnitedHealth Group were worth $5,736,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Richelieu Gestion SA purchased a new stake in UnitedHealth Group in the fourth quarter valued at $26,000. CGC Financial Services LLC raised its position in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $31,000. LFA Lugano Financial Advisors SA grew its stake in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 2.9 %

UnitedHealth Group stock opened at $494.43 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $455.07 billion, a P/E ratio of 30.22, a PEG ratio of 1.48 and a beta of 0.60. The stock has a 50-day simple moving average of $498.34 and a 200-day simple moving average of $501.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business earned $6.26 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.70%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on UNH. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Robert W. Baird began coverage on UnitedHealth Group in a research note on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, June 12th. Finally, StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.